The short and long-term dynamics of opioid/stimulant use: Mixed methods to informoverdose prevention and treatment related to polysubstance use
阿片类药物/兴奋剂使用的短期和长期动态:与多物质使用相关的过量预防和治疗的混合方法
基本信息
- 批准号:10590209
- 负责人:
- 金额:$ 215.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2025-09-29
- 项目状态:未结题
- 来源:
- 关键词:Accidental InjuryAcquired Immunodeficiency SyndromeAddressAreaBehavioralCause of DeathCessation of lifeClinicalClinical DataCocaineCohort StudiesCommunitiesDataData CollectionData SourcesEcological momentary assessmentEnrollmentFentanylFoundationsFundingGoalsHelping to End Addiction Long-termIndividualInjecting drug userInjectionsInterventionIntravenousJointsKnowledgeLaboratoriesLinkLongitudinal trendsMethodsNational Institute of Drug AbuseNatureNorth AmericaOpiate AddictionOpioidOverdoseOverdose reductionParticipantPatternPersonsPharmaceutical PreparationsPharmacological TreatmentPoliciesPreventionProtocols documentationPublic HealthQualitative ResearchReadinessRecording of previous eventsResearchResearch DesignResearch MethodologyRiskRoleRunningSamplingServicesStandardizationStimulantSubstance Use DisorderSystemTimeTime trendTreatment outcomeUnited StatesUnited States National Institutes of Healthbasecohortdesignevidence baseexperiencefollow-uphealinghigh riskimplementation strategyimprovedimproved outcomeinnovationmachine learning methodmortalitynon-opioid analgesicopioid epidemicopioid misuseopioid mortalityopioid useopioid use disorderopioid useroverdose deathoverdose preventionoverdose riskpolysubstance useprevention servicerecruitresponsesocial determinantsstimulant usesubstance use treatmentsynthetic opioidtheories
项目摘要
Project Summary. Overdose deaths surpassed 100,000 in the United States in 2020. While opioid-related
deaths largely attributable to fentanyl continue to rise, deaths involving stimulants, including cocaine, have
increased by over 300% since 2013. A growing driver of the continued overdose crisis in the US is the role of
concurrent use of multiple substances. Although there are pharmacological treatments to address opioid use
disorder, few evidence-based options are available for addressing concurrent stimulant use among people
using opioids. Understanding the dynamics of polysubstance use, particularly opioid and stimulant co-use, and
the role of treatment with respect to the dynamics of co-use, is critical to inform ongoing overdose prevention.
Yet, there are major gaps in our knowledge regarding the patterns and trajectories of opioid and stimulant co-
use and their role in overdose. There is an urgent need to characterize the longitudinal nature of polysubstance
use, treatment utilization, and overdose in community-based samples. The overarching objective of this
proposal is to further our understanding of both long- and short-term patterns of opioid/stimulant use and
examine the longitudinal relationship between co-use of opioids/stimulants and substance use treatment and
non-fatal and fatal overdose over time, in order to inform treatment and overdose prevention services. We
propose the following three specific aims: 1) To characterize long-term patterns of opioid and stimulant co-use
and examine the relationship between trajectories of co-use, substance use treatment, overdose and mortality;
2) To examine real-time short-term patterns and transitions in and out of opioid and stimulant co-use and their
association with substance use treatment and overdose; and 3) To assess opportunities and readiness for
expanding and strengthening service capacity related to treatment and overdose among those with different
patterns of opioid/stimulant use. To achieve these aims, we will leverage over 30 years of behavioral,
laboratory and clinical data from among over 5,000 people who inject drugs within the AIDS Linked to the
IntraVenous Experience (ALIVE) cohort to examine long-term trends and the social determinants of concurrent
opioid/stimulant use. Supplemented with new recruitment of the Stimulant Opioid Non-Injection Cohort
(SONIC), we will conduct new ecological momentary assessments in both samples to examine micro-patterns
of use and employ state-of-the-art machine learning methods to identify patterns and their association with
treatment and overdose over time in this community-based sample at high risk of overdose. Qualitative
research with stakeholders and people with differing patterns of opioid/stimulant co-use will highlight gaps and
challenges within the service system and identify specific implementation strategies to increase capacity to
address heterogeneous concurrent opioid/stimulant use and related needs. The results of this study will
provide evidence to inform intervention and policy to improve outcomes for people who use multiple
substances with the goal of reducing overdose deaths in the US in the context of synthetic opioids.
项目摘要。服用过量死亡在2020年美国超过100,000。
芬太尼基本上的死亡继续升高,包括可卡因在内的兴奋剂的死亡已有
自2013年以来,增长了300%以上。美国持续过量危机的驱动力越来越多。
同时使用多种物质。尽管有药理治疗方法可以解决阿片类药物的使用
疾病,几乎没有证据的选择可用于解决人们的同时兴奋剂使用
使用阿片类药物。了解使用多物质使用的动态,尤其是阿片类药物和兴奋剂共同使用,以及
治疗在共同利用动力学方面的作用对于告知正在进行的预防过量的情况至关重要。
然而,关于阿片类药物和刺激性共同的模式和轨迹的知识,我们的知识存在很大的差距
使用及其在用药过量中的作用。迫切需要表征polysubstance的纵向性质
在基于社区的样本中使用,治疗利用和过量。这个总体目标
提议是为了进一步了解阿片类药物/兴奋剂的长期和短期模式以及
检查阿片类药物/兴奋剂的共同使用与物质使用治疗与药物的纵向关系
随着时间的流逝,非致命和致命的服用过量,以告知治疗和预防服务过量。我们
提出以下三个特定目的:1)表征阿片类药物和兴奋剂共同使用的长期模式
并检查共同使用,药物治疗,过量和死亡率的轨迹之间的关系;
2)检查实时的短期模式和过渡在阿片类药物和兴奋剂共同使用及其中
与药物使用治疗和过量相关; 3)评估机会和准备
扩大和增强与治疗和服用过量相关的服务能力
阿片类药物/兴奋剂的使用模式。为了实现这些目标,我们将利用超过30年的行为,
来自5,000多名注射毒品的人中的实验室和临床数据
静脉经历(活着)的队列,以检查长期趋势和并发的社会决定因素
阿片类药物/兴奋剂的使用。补充了刺激性阿片类药物非注入队列的新招募
(Sonic),我们将在两个样品中进行新的生态瞬时评估以检查微观图案
使用并采用最先进的机器学习方法来识别模式及其与之关联
随着时间的推移,在这个基于社区的样本中随着时间的流逝而过量服用过量的样本。定性
与利益相关者和具有不同模式的阿片类药物/兴奋剂共同使用的人进行的研究将突出差距和
服务系统内的挑战并确定具体的实施策略,以提高能力
解决异质的并发阿片类药物/兴奋剂的使用和相关需求。这项研究的结果将
提供证据以告知干预和政策以改善使用多重人的结果
在合成阿片类药物的背景下,其目的是减少美国过量死亡的目的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIELLE GERMAN其他文献
DANIELLE GERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIELLE GERMAN', 18)}}的其他基金
The short and long-term dynamics of opioid/stimulant use: Mixed methods to informoverdose prevention and treatment related to polysubstance use
阿片类药物/兴奋剂使用的短期和长期动态:与多物质使用相关的过量预防和治疗的混合方法
- 批准号:
10841942 - 财政年份:2023
- 资助金额:
$ 215.81万 - 项目类别:
Mixed methods study of polysubstance use to optimize overdose prevention
使用多种物质优化过量预防的混合方法研究
- 批准号:
10708120 - 财政年份:2022
- 资助金额:
$ 215.81万 - 项目类别:
Mixed methods study of polysubstance use to optimize overdose prevention
使用多种物质优化过量预防的混合方法研究
- 批准号:
10579678 - 财政年份:2022
- 资助金额:
$ 215.81万 - 项目类别:
Social networks, social resources, and HIV transmission
社交网络、社会资源和艾滋病毒传播
- 批准号:
9916779 - 财政年份:2016
- 资助金额:
$ 215.81万 - 项目类别:
Sexual HIV risk among Thai methamphetamine users
泰国冰毒使用者的艾滋病毒性风险
- 批准号:
7215588 - 财政年份:2005
- 资助金额:
$ 215.81万 - 项目类别:
Sexual HIV risk among Thai methamphetamine users
泰国冰毒使用者的艾滋病毒性风险
- 批准号:
7062621 - 财政年份:2005
- 资助金额:
$ 215.81万 - 项目类别:
Sexual HIV risk among Thai methamphetamine users
泰国冰毒使用者的艾滋病毒性风险
- 批准号:
7283003 - 财政年份:2005
- 资助金额:
$ 215.81万 - 项目类别:
Sexual HIV risk among Thai methamphetamine users
泰国冰毒使用者的艾滋病毒性风险
- 批准号:
7496936 - 财政年份:2005
- 资助金额:
$ 215.81万 - 项目类别:
相似海外基金
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core - EIS
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686546 - 财政年份:2023
- 资助金额:
$ 215.81万 - 项目类别:
Dose Flexible Combination 3D-Printed Delivery Systems for Antiviral Therapy in Children
用于儿童抗病毒治疗的剂量灵活组合 3D 打印输送系统
- 批准号:
10682185 - 财政年份:2023
- 资助金额:
$ 215.81万 - 项目类别: